Αρχειοθήκη ιστολογίου

Τρίτη 16 Οκτωβρίου 2018

Treatment of early-stage laryngeal cancer: A comparison of treatment options

Publication date: December 2018

Source: Oral Oncology, Volume 87

Author(s): Brandon Jackson Baird, C. Kwang Sung, Beth M. Beadle, Vasu Divi

Abstract

Over the course of the last several decades, the treatment options for early laryngeal cancers (T1 and T2) have evolved; however, simultaneously the mortality rate has increased. As larynx preservation approaches have become the standard of care, the selection of the proper treatment modality has become paramount. Radiation therapy or transoral laser microsurgery are the most common options for treatment of these early lesions. Oncologic and functional outcomes are considered equivalent between the two modalities for early glottic cancers; however, no direct comparisons exist for robust analysis. In terms of larynx preservation, there also is not compelling data favoring one treatment option or another. For early stage lesions, the goal for any larynx-sparing technique, either radiation or surgery, should be the intent to cure with single modality treatment and minimal short- and long-term toxicity. This article is designed to create a frame of reference for managing early stage disease with respect to lesions of the glottis and supraglottis while weighing treatment implications from an oncologic, functional, and cost perspective.



https://ift.tt/2IYduZ5

Δεν υπάρχουν σχόλια:

Δημοσίευση σχολίου